Lv33
322 积分 2022-11-04 加入
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
6小时前
已完结
The therapeutic efficacy of 5-ALA based photodynamic therapy and chemotherapy combination in triple negative breast cancer cells
26天前
已关闭
Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer
28天前
已完结
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b Study
28天前
已完结
Eribulin mesylate (halichondrin B analog E7389) in platinum‐resistant and platinum‐sensitive ovarian cancer
28天前
已完结
[Consensus on recurrence risk and clinical management of HR+/HER-2- early breast cancer (2025 edition)]
1个月前
已完结
Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
1个月前
已完结
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials
1个月前
已关闭
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
1个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
1个月前
已完结
皖公网安备34019202002308
